Glutamine/(Creatine and Phosphocreatine) ratio
|
Basic information |
| Metabolite name | Glutamine/(Creatine and Phosphocreatine) ratio |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 11 |
|
Basic information |
| Metabolite name | Glutamine/(Creatine and Phosphocreatine) ratio |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 11 |
|
Relationship between Glutamine/(Creatine and Phosphocreatine) ratio and depression (count: 11) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M264 | Type1 | depression group vs. control group | Hippocampus | Human | Down |
| Study M272 | Type1 | MDDhA group vs. control group | Pregenual anterior cingulate cortex | Human | Down |
| Study M294 | Type1 | CMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M294 | Type1 | CMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M334 | Type1 | depression group vs. control group | Dorsal prefrontal cortex | Human | Up |
| Study M335 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Up |
| Study M350 | Type1 | depression group vs. control group | Medial prefrontal cortex | Human | Down |
| Study M350 | Type1 | depression group vs. control group | Amygdala | Human | Down |
| Study M350 | Type1 | depression group vs. control group | Hippocampus | Human | Down |
| Study M521 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M538 | Type2 | MDD group, after rTMS treatment vs. baseline | Dorsolateral prefrontal cortex | Human | Up |
| Study M546 | Type1 | CUS offspring group vs. control offspring group, right hippocampus of male offspring | Hippocampus | Sprague-Dawley rat | Up |
| Study M654 | Type1 | CRS group, after vs. before stress | Sensorimotor cortex | Sprague-Dawley rat | Down |
| Study M944 | Type1 | MDD group vs. control group | Pregenual anterior cingulate cortex | Human | Up |